Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

66°
- Benton, AR (72018)
  Today
  
  Considerable clouds this evening. Some decrease in clouds late. Low 64F. Winds S at 5 to 10 mph..
  
  Tonight
  
  Considerable clouds this evening. Some decrease in clouds late. Low 64F. Winds S at 5 to 10 mph.
  
  Updated: November 17, 2025 @ 8:22 pm
- Full Forecast

- Site search

Home
News
- Local News
Sports
Obituaries
Multimedia
- Photo Galleries
- Videos
e-Edition
Classifieds
Archives
Readers Choice 2025

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Novartis AG Common Stock (NY:NVS)

131.55 +0.29 (+0.22%)

Official Closing Price Updated: 7:00 PM EST, Nov 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novartis AG Common Stock

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

51 52 Next >

From Years to Months: How AI is Shaping the Landscape of Clinical Trials ↗

September 22, 2023

Pharmaceutical companies are harnessing artificial intelligence (AI) to speed up the traditionally arduous process of clinical trials, potentially saving both time and significant sums of money. These...

Via Benzinga

Topics Artificial Intelligence

Preventable Vaccines Market May See a Big Move : AstraZeneca, GlaxoSmithKline, Merck

September 19, 2023

Stay up-to-date with Preventable Vaccines Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.

Via SBWire

Amazon Poaches Microsoft's Product Chief, Google And DoD Team Up For AI-Powered Microscope To Identify Cancer, Rocket Lab's 41st Mission Succumbed To Technical Issues: Today's Top Stories ↗

September 19, 2023

Bloomberg

Via Benzinga

2 Dividend Stocks to Buy and Hold Forever ↗

September 13, 2023

These companies' prospects look secure.

Via The Motley Fool

Price Over Earnings Overview: Novartis ↗

September 01, 2023

Via Benzinga

Peering Into Novartis's Recent Short Interest ↗

August 31, 2023

Via Benzinga

Chinese Drugmaker BeiGene And Novartis Move Out From Second Cancer Drug Pact ↗

September 19, 2023

BeiGene Ltd (NASDAQ: BGNE) said it would regain rights to develop, manufacture, and commercialize Tevimbra (tislelizumab), its cancer drug, from Novartis AG (NYSE: NVS).

Via Benzinga

AMC Stock Alert: Adam Aron Teases New Chocolate, Wine Brands for AMC ↗

September 15, 2023

AMC Entertainment (AMC) stock is a hot topic on Friday after the movie theater chain's CEO teased that new products are on the way.

Via InvestorPlace

Why Is Canopy Growth (CGC) Stock Up 14% Today? ↗

September 15, 2023

Canopy Growth (CGC) stock is rising higher on Friday after the cannabis company announced it won't fund BioSteel Sports Nutrition any longer.

Via InvestorPlace

Topics Cannabis

NVS Stock Alert: Novartis Shareholders Approve Sandoz Spinoff ↗

September 15, 2023

Novartis (NVS) stock is rising higher on Friday after the company announced approval for the spinoff of its generic drugs business Sandoz.

Via InvestorPlace

Instacart Mulls IPO Price Hike After Arm's Stellar Debut, UAW Launches Historic Simultaneous Strike, China Sanctions Lockheed Martin & Northrop Grumman Concerning Taiwan Arms Sales: Today's Top Stories ↗

September 15, 2023

Wall Street Journal

Via Benzinga

Topics Initial Public Offering

Have Million-Dollar Gene Therapies Finally Reached An Inflection Point? ↗

September 15, 2023

Gene therapies are clearing the FDA and reaching seriously ill patients. They could cost millions.

Via Investor's Business Daily

Sandoz Pushes Product Launch Plans As Novartis Shareholders Approve The Spin-Off ↗

September 15, 2023

At an Extraordinary General Meeting, Novartis AG's (NYSE: NVS) shareholders

Via Benzinga

AI Integration In Biotech & Pharma: Companies Positioned To Benefit ↗

September 11, 2023

The convergence of artificial intelligence (AI) with the biotech and pharmaceutical sectors is ushering in a new era of innovation. AI is catalyzing transformations from drug discovery to patient care....

Via Benzinga

Topics Artificial Intelligence

Qualcomm-Apple's Chip Supply Agreement, Alleged Report About AstraZeneca CEO Sir Pascal Soriot's Intention To Step Down, Apple & Google Face Off in Antitrust Showdown: Today's Top Stories ↗

September 11, 2023

Benzinga Qualcomm Announces Chip Supply Agreement With Apple

Via Benzinga

Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis' Sandoz Inks Pact With Samsung Bioepis ↗

September 11, 2023

Sandoz, a generic and biosimilar medicines unit of Novartis AG (NYSE: NVS), has

Via Benzinga

AI 2.0 is Here: How to Invest in a Generational Opportunity

September 08, 2023

AI is sweeping the world but don't confuse apples with oranges; here's a look at the top 5 advancements in AI and who is using it.

Via MarketBeat

Topics Artificial Intelligence Supply Chain

Could This Biosimilar Drug Be Novartis' Next Blockbuster? ↗

September 05, 2023

Novartis expects to submit regulatory applications for its biosimilar soon.

Via The Motley Fool

8 Pharma Stocks Affected by New Drug Price Negotiation Rules ↗

September 02, 2023

Which companies have the most to lose now that Medicare can negotiate directly with them on the prices of some of the most widely used drugs?

Via The Motley Fool

How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?

September 01, 2023

Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects.

Via MarketBeat

Topics Economy

Biden Administration Vs. Big Pharma: What the Legal Showdown Means for Your Wallet ↗

August 31, 2023

The Biden administration's move to lower drug prices has prompted a flurry of legal challenges.

Via Benzinga

Sex Hormones Market to See Huge Growth by 2028 : Novartis, Sanofi, AstraZeneca, Merck

August 30, 2023

Sex Hormones- Comprehensive Study by Type (Progesterone, Testosterone, Drospirenone), Application (Topical, Inhalation, Injection, Others) Players and Region - Global Market Outlook to 2027

Via SBWire

What Impact Will Medicare Price Negotiations Have on Big Pharma Stocks? ↗

August 29, 2023

Investors appear to be yawning for the most part at the latest news on Medicare drug price negotiations.

Via The Motley Fool

Transdermal Drug Patches Market to See Huge Growth : Novartis, Mylan, Accrux

August 29, 2023

Stay up-to-date with Transdermal Drug Patches Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.

Via SBWire

Important Data Ahead, Tesla Turning On Massive Nvidia Cluster, 10 Drugs Name For Price Cuts ↗

August 29, 2023

To gain an edge, this is what you need to know today.

Via Benzinga

Biden Targets Cancer, Diabetes Drugs In Controversial Medicare Price Battle ↗

August 29, 2023

The Centers for Medicare and Medicaid Services unveiled the first ten drugs subject to price negotiations under President Joe Biden's Inflation Reduction Act, including:

Via Benzinga

Blockbusters From AbbVie, Merck, Lilly Highlight List Of 10 Drugs Subject To Price Cuts ↗

August 29, 2023

The Biden administration is planning to negotiate the prices of 10 drugs in 2026.

Via Investor's Business Daily

3 AI Stocks With the Potential to Transform Your Financial Future ↗

August 28, 2023

Are you looking to invest in AI stocks? Here are three picks with the potential to transform your financial future.

Via InvestorPlace

Topics Artificial Intelligence

3 Emerging Market Stocks to Buy in August ↗

August 28, 2023

These three emerging market stocks to buy in August will have very strong, positive catalysts going forward.

Via InvestorPlace

Exelixis' Lead Cancer Treatment Delivers Another Surprise, Though Analyst Finds Commercial Opportunity In Pancreatic Neuroendocrine Modest ↗

August 24, 2023

Thursday, Exelixis Inc (NASDAQ: EXEL) announced that the Alliance for Clinical Trials in Oncology independent Data and Safety Monitoring Board (DSMB) unanimously recommended to unblind and stop the...

Via Benzinga

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

51 52 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Announcements
e-Edition
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

bentoncourier.com
321 North Market Street
Benton, AR 72018
Phone: 501-315-8228
Email: bcadmin@bentoncourier.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Benton, AR (72018)

Today

Tonight

Novartis AG Common Stock (NY:NVS)

All News about Novartis AG Common Stock

Sections

Services

Follow Us